{"id":"https://openalex.org/W2026465657","doi":"https://doi.org/10.2174/138161210791293051","title":"Using Functional Neuroimaging to Investigate the Mechanisms of Action of Selective Serotonin Reuptake Inhibitors (SSRIs)","display_name":"Using Functional Neuroimaging to Investigate the Mechanisms of Action of Selective Serotonin Reuptake Inhibitors (SSRIs)","alternate_titles":[],"publication_year":2010,"publication_date":"2010-05-12","ids":{"openalex":"https://openalex.org/W2026465657","doi":"https://doi.org/10.2174/138161210791293051","mag":"2026465657","pmid":"https://pubmed.ncbi.nlm.nih.gov/20370666"},"language":"en","primary_location":{"id":"doi:10.2174/138161210791293051","doi":"https://doi.org/10.2174/138161210791293051","is_oa":false,"landing_page_url":"https://doi.org/10.2174/138161210791293051","pdf_url":null,"source":{"id":"https://openalex.org/S55674637","display_name":"Current Pharmaceutical Design","issn_l":"1381-6128","issn":["1381-6128","1873-4286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Design","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2026465657"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085604448","display_name":"Susannah Elinor Murphy","orcid":"https://orcid.org/0000-0001-8995-2099","observed_orcids":["https://orcid.org/0000-0001-8995-2099"]},"institutions":[{"id":"https://openalex.org/I2803066836","display_name":"Warneford Hospital","ror":"https://ror.org/03we1zb10","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802171185","https://openalex.org/I2803066836"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Susannah E. Murphy","raw_affiliation_strings":["Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX37JX, UK. susannah.murphy@psych.ox.ac.uk","Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX37JX, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX37JX, UK. susannah.murphy@psych.ox.ac.uk","institution_ids":["https://openalex.org/I2803066836","https://openalex.org/I40120149"]},{"raw_affiliation_string":"Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX37JX, UK","institution_ids":["https://openalex.org/I2803066836","https://openalex.org/I40120149"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5085604448"],"corresponding_institution_ids":["https://openalex.org/I2803066836","https://openalex.org/I40120149"],"apc_list":null,"apc_paid":null,"fwci":3.165,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.90180737,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"16","issue":"18","first_page":"1990","last_page":"1997"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.7681000232696533,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.7681000232696533,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.18469999730587006,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.020600000396370888,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":1.0},{"id":"https://openalex.org/keywords/mechanisms-of-drug-action","display_name":"mechanisms of drug action","score":0.746999979019165},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.8100000023841858},{"id":"https://openalex.org/keywords/anxiety-disorders","display_name":"anxiety disorders","score":1.0},{"id":"https://openalex.org/keywords/emotional-processing","display_name":"emotional processing","score":0.675000011920929},{"id":"https://openalex.org/keywords/antidepressant-effects","display_name":"antidepressant effects","score":0.656000018119812},{"id":"https://openalex.org/keywords/functional-neuroimaging","display_name":"functional neuroimaging","score":0.7239999771118164},{"id":"https://openalex.org/keywords/serotonergic-drugs","display_name":"serotonergic drugs","score":0.628000020980835},{"id":"https://openalex.org/keywords/preclinical-to-clinical-translation","display_name":"preclinical to clinical translation","score":0.628000020980835}],"concepts":[{"id":"https://openalex.org/C25876315","wikidata":"https://www.wikidata.org/wiki/Q15197465","display_name":"Neurochemical","level":2,"score":0.7572067975997925},{"id":"https://openalex.org/C58693492","wikidata":"https://www.wikidata.org/wiki/Q551875","display_name":"Neuroimaging","level":2,"score":0.6851301789283752},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.6123343110084534},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.5467345714569092},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5259321331977844},{"id":"https://openalex.org/C89611455","wikidata":"https://www.wikidata.org/wiki/Q6804646","display_name":"Mechanism (biology)","level":2,"score":0.5092786550521851},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.504930317401886},{"id":"https://openalex.org/C52338299","wikidata":"https://www.wikidata.org/wiki/Q1004354","display_name":"Functional neuroimaging","level":3,"score":0.4914175271987915},{"id":"https://openalex.org/C37000724","wikidata":"https://www.wikidata.org/wiki/Q50430226","display_name":"Serotonergic","level":4,"score":0.49082502722740173},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3347674012184143},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.2611967623233795},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.22211778163909912},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.14713317155838013},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.0},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001008","descriptor_name":"Anxiety Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001008","descriptor_name":"Anxiety Disorders","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D003952","descriptor_name":"Diagnostic Imaging","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.2174/138161210791293051","doi":"https://doi.org/10.2174/138161210791293051","is_oa":false,"landing_page_url":"https://doi.org/10.2174/138161210791293051","pdf_url":null,"source":{"id":"https://openalex.org/S55674637","display_name":"Current Pharmaceutical Design","issn_l":"1381-6128","issn":["1381-6128","1873-4286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Design","raw_type":"journal-article"},{"id":"pmid:20370666","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20370666","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current pharmaceutical design","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2325530271","https://openalex.org/W2095986387","https://openalex.org/W2144743430","https://openalex.org/W7213976829","https://openalex.org/W4403129586","https://openalex.org/W2943359078","https://openalex.org/W2167738136","https://openalex.org/W2946318843","https://openalex.org/W2463556195","https://openalex.org/W3133835791"],"abstract_inverted_index":{"Selective":[0],"serotonin":[1],"reuptake":[2],"inhibitors":[3],"(SSRIs)":[4],"are":[5,90],"effective":[6],"in":[7,74,85,142,168,172,204,208],"the":[8,27,42,57,60,79,96,109,117,136,146,157,193,199,216,230],"treatment":[9],"of":[10,15,31,38,41,63,78,82,111,120,138,159,166,232],"depression":[11,209],"and":[12,54,66,84,150,195,210,223],"a":[13,36,177,236],"range":[14],"anxiety":[16,211],"disorders":[17],"[1;2].":[18],"Preclinical":[19],"models":[20],"have":[21],"been":[22],"relatively":[23],"successful":[24],"at":[25],"elucidating":[26],"key":[28,178,237],"neurochemical":[29,61],"effects":[30,51,62],"these":[32,47,64,183],"serotonergic":[33],"agents;":[34],"however,":[35],"lack":[37],"understanding":[39,76],"exists":[40],"functional":[43,112,179,217],"mechanisms":[44,137],"by":[45,124],"which":[46,182,240],"drugs":[48,65],"exert":[49,185,242],"their":[50,67,186,243],"on":[52],"mood":[53],"anxiety.":[55],"Elucidating":[56],"link":[58],"between":[59,148],"therapeutic":[68,244],"action":[69,140],"is":[70,108,235],"an":[71,128,131],"essential":[72],"step":[73],"further":[75],"some":[77],"current":[80],"limitations":[81],"SSRIs,":[83],"developing":[86],"novel":[87],"agents":[88,184],"that":[89,163,202,229],"more":[91],"selectively":[92],"designed":[93],"to":[94,115,134,156,227],"target":[95],"symptoms":[97],"they":[98],"treat.":[99],"An":[100],"increasingly":[101],"popular":[102],"experimental":[103],"method":[104],"within":[105],"psychopharmacological":[106],"research":[107],"use":[110],"neuroimaging":[113,196,218],"techniques":[114],"investigate":[116,135],"pharmacological":[118],"modulation":[119,165],"task-induced":[121],"brain":[122],"activity":[123,167],"psychoactive":[125],"drugs.":[126],"Such":[127],"approach":[129,155],"offers":[130],"exciting":[132],"opportunity":[133],"drug":[139],"and,":[141],"this":[143,154],"way,":[144],"bridge":[145],"gap":[147],"preclinical":[149],"clinical":[151,188],"studies.":[152],"Applying":[153],"study":[158],"SSRIs":[160,241],"has":[161],"highlighted":[162],"direct":[164],"neural":[169],"areas":[170],"involved":[171],"emotional":[173],"processing":[174,206],"may":[175],"represent":[176],"mechanism":[180,238],"through":[181,239],"antidepressant":[187],"effects.":[189,245],"This":[190],"review":[191],"summarises":[192],"cognitive":[194],"evidence":[197],"suggesting":[198],"critical":[200],"role":[201],"disruptions":[203,234],"emotion-related":[205],"play":[207],"disorders.":[212],"It":[213],"then":[214],"examines":[215],"evidence,":[219],"from":[220],"both":[221],"patient":[222],"healthy":[224],"volunteer":[225],"studies,":[226],"suggest":[228],"amelioration":[231],"such":[233]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2026465657","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
